{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:23:34Z","timestamp":1790645014040,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"DOI":"10.1007\/s40520-022-02141-9","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T08:02:43Z","timestamp":1652947363000},"page":"3151-3153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The new therapy for Alzheimer\u2019s disease: from a hope for a few to a false hope?"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5313-8631","authenticated-orcid":false,"given":"Stefania","family":"Orini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-1678","authenticated-orcid":false,"given":"Cristina","family":"Geroldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5408-0048","authenticated-orcid":false,"given":"Orazio","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"2141_CR1","volume-title":"World Alzheimer report 2018","author":"C Patterson","year":"2018","unstructured":"Patterson C (2018) World Alzheimer report 2018. Alzheimer\u2019s Disease International, London"},{"key":"2141_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"2141_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12213","volume":"17","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Jones DT, Greicius MD (2021) Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement 17:696\u2013701. https:\/\/doi.org\/10.1002\/alz.12213","journal-title":"Alzheimers Dement"},{"key":"2141_CR4","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1007\/s10072-021-05497-4","volume":"42","author":"F Tagliavini","year":"2021","unstructured":"Tagliavini F, Tiraboschi P, Federico A (2021) Alzheimer\u2019s disease: the controversial approval of Aducanumab. Neurol Sci 42:3069\u20133070. https:\/\/doi.org\/10.1007\/s10072-021-05497-4","journal-title":"Neurol Sci"},{"key":"2141_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1056\/NEJMp2110468","volume":"26","author":"GC Alexander","year":"2021","unstructured":"Alexander GC, Knopman DS, Emerson SS et al (2021) Revisiting FDA Approval of Aducanumab. N Engl J Med 26:769\u2013771. https:\/\/doi.org\/10.1056\/NEJMp2110468","journal-title":"N Engl J Med"},{"key":"2141_CR6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.14283\/jpad.2021.41","volume":"8","author":"J Cummings","year":"2021","unstructured":"Cummings J, Aisen P, Apostolova LG et al (2021) Aducanumab: appropriate use recommendations. J Prev Alzheimers Dis. 8:398\u2013410. https:\/\/doi.org\/10.14283\/jpad.2021.41","journal-title":"J Prev Alzheimers Dis."},{"key":"2141_CR7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jamainternmed.2021.6045","volume":"181","author":"EA Largent","year":"2021","unstructured":"Largent EA, Peterson A, Lynch HF (2021) FDA drug approval and the ethics of desperation. JAMA Intern Med 181:1555\u20131556. https:\/\/doi.org\/10.1001\/jamainternmed.2021.6045","journal-title":"JAMA Intern Med"},{"key":"2141_CR8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H et al (2020) Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol 19:951\u2013962. https:\/\/doi.org\/10.1016\/S1474-4422(20)30314-8","journal-title":"Lancet Neurol"},{"key":"2141_CR9","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1111\/jgs.17390","volume":"69","author":"M Canevelli","year":"2021","unstructured":"Canevelli M, Rossi PD, Astrone P et al (2021) \u201cReal world\u201d eligibility for aducanumab. J Am Geriatr Soc 69:2995\u20132998. https:\/\/doi.org\/10.1111\/jgs.17390","journal-title":"J Am Geriatr Soc"},{"key":"2141_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.17530","author":"A Padovani","year":"2021","unstructured":"Padovani A, Caratozzolo S, Rozzini L et al (2021) \u201cReal-world\u201deligibility for aducanumab depends on clinical setting and patients\u2019 journey. J Am Geriatr Soc. https:\/\/doi.org\/10.1111\/jgs.17530","journal-title":"J Am Geriatr Soc"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-022-02141-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-022-02141-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-022-02141-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T10:26:53Z","timestamp":1670236013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-022-02141-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":10,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1007\/s40520-022-02141-9","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Study design was approved by the local ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Written was obtained from each patient or from a legally authorized decision-maker.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}